Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Neuropharmacology. 2013 Feb 24;70:268–277. doi: 10.1016/j.neuropharm.2013.02.009

Figure 2.

Figure 2

Effects of CP55,940 on elevated plus maze test in C57BL/6 mice pre-exposed to chronic treatment of vehicle (polyethylene glycol: saline = 9:1) (VEH1) or AM251 (1 mg/kg/day, IP for 21 days). For all groups, n= 10–12. Doses are given in mg/kg (IP). Values represent mean ± SEM for each treatment. VEH2, vehicle of CP55,940 (Tween 80:polyethylene glycol: saline = 18:1:1); * P<0.05, ** P<0.01 compared with VEH1+VEH2; #P<0.05, ##P<0.01 compared with AM251+VEH2.